Status:
UNKNOWN
Study KBP-2020-CPHG Documenting New Cases of Primary Lung Cancer (PLC) Diagnosed in Respiratory Medicine Departments and Lung Cancer Units at General Hospitals From January 1st to December 31st 2020
Lead Sponsor:
Collège des Pneumologues des Hôpitaux Généraux
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Twenty years after KBP-2000-CPHG study and ten years after KBP-2010-CPHG study, the CPHG proposes to conduct a new epidemiological study on primary PLC in order to evaluate and analyze the changes tha...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Primary Lung Cancer histologically (or cytologically or presence of a mutation on liquid biopsy with compatible imaging) proven between January 1st and December 31st, 2020\*
- Follow-up by a lung specialist at a General Hospital
- Oral informed consent \* date of collected sample
Exclusion
- Age \< 18 years
- Secondary lung cancer
- Recurrence of same histological type PLC- left to the investigator discretion according to the clinic and the imagery
- Previous enrolment in the study
- Freedom deprived patient following a legal or administrative decision
- Patient unable to give his(her) consent
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT04402099
Start Date
January 1 2020
End Date
January 1 2026
Last Update
June 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Collège des Pneumologues des Hôpitaux Généraux (CPHG) (General Hospital Pulmonologists College)
Paris, France, 75006